Medscape

• 1. Introduction

  ›

  Medscape launched on the 22nd of May 1995, before most people had ever bought anything online, before social media existed, before smartphones. A company called SCP Communications, Inc. brought it to life under the direction of CEO Peter Frishauf, with a vision that sounds obvious in hindsight: give doctors, nurses, and researchers reliable medical information through a website. The first editor was a physician assistant named Stephen Smith. From that modest beginning, Medscape grew into one of the internet's most-visited resources for healthcare professionals, hosting drug references, continuing medical education, medical news, and a gateway to the National Library of Medicine's MEDLINE database. But that growth came with contradictions. Who controls what clinicians read? Who pays for it? And what happens when the line between education and industry influence becomes harder to see?

• 2. The Lundberg Years

  ›

  George D. Lundberg arrived at Medscape in 1999 carrying serious credentials. For seventeen years before joining, he had served as editor of the Journal of the American Medical Association, one of the most prestigious medical publications in the world. His presence signaled that Medscape was serious about editorial weight. That same September, Medscape, Inc. went public on NASDAQ under the ticker symbol MSCP, a sign of the investor optimism surrounding medical information on the internet. The following year, Medscape merged with MedicaLogic, Inc., another publicly traded company. The combination did not hold. MedicaLogic filed for bankruptcy within eighteen months and sold Medscape to WebMD in December 2001. Lundberg stayed on through the ownership change, but in 2008 WebMD terminated him. The year after his departure, the Medscape Journal of Medicine, which had once been one of seven peer-reviewed electronic journals Medscape published, ceased publishing entirely.

• 3. Editorial Reinvention

  ›

  In January 2013, Eric Topol was named editor-in-chief of Medscape, marking the start of a new editorial chapter. That same year, George Lundberg returned to the organization in a different capacity, serving as editor-at-large. The dual appointment reflected the complexity of Medscape's identity: a commercial platform trying to maintain serious medical authority. By this point, Medscape had also expanded well beyond the desktop browser. WebMD had released an iOS application in 2009, followed by an Android version two years later. In 2015 came Medscape CME and Education on iOS, designed to deliver continuing medical education directly to clinicians through their phones. The platform's reach extended geographically in 2021, when Medscape launched Medscape UK to grow its presence in the United Kingdom.

• 4. Questions of Trust

  ›

  A 2016 survey of doctors found WebMD and its sister company Medscape to carry incomplete medical information lacking depth, along with numerous instances of misinformation. A separate study found both services to lack neutrality, with potential bias linked to unusually high payments from the pharmaceutical industry relative to competitors. Dr. Yoni Freedhoff, MD, Associate Professor of Family Medicine at the University of Ottawa and medical director of the Bariatric Medical Institute, made the criticism personal in 2012. He published an article titled "Why I Can No Longer Trust Medscape," accusing the platform of "putting patients at risk by actively misinforming their physicians." He pointed specifically to poor vetting of the studies Medscape chose to publish. Then in April 2024, a sharper controversy surfaced. Medscape was criticized for running educational content funded by Philip Morris International, the tobacco transnational. Critics argued that the tobacco industry had no place in medical education. Medscape responded that the content met accreditation standards, but announced it would no longer accept funding from tobacco-affiliated organizations. It also withdrew from a multimillion-dollar arrangement with Philip Morris International that had included plans to deliver thirteen programs under the name the "PMI Curriculum," along with podcasts and a television-style series.

• 5. Into the AI Era

  ›

  In November 2025, Medscape launched Medscape AI, a generative artificial intelligence tool built for clinicians. The platform draws on Medscape's own proprietary content alongside peer-reviewed literature from more than four hundred medical journals, and it incorporates real-time medical news. Medscape described the tool as designed to exclude unverified information from the open internet, providing cited responses with regular human editorial oversight. The development process involved direct input from clinicians. Medscape AI is available at no cost to registered Medscape users. Whether that model of editorial oversight can satisfy the critics who questioned Medscape's independence from industry pressure remains an open question that the platform's new AI layer has only made more pressing.